Laffer Tengler Investments Regeneron Pharmaceuticals, Inc. Transaction History

Laffer Tengler Investments

  • $494 Billion
  • Q3 2024

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023
SELL
$692.45 - $844.37 $1.69 Million - $2.06 Million
-2,443 Reduced 99.55%
11 $9.05 Million
Q2 2023

Aug 14, 2023
BUY
$700.03 - $830.35 $1.72 Million - $2.04 Million
2,454 New
2,454 $1.76 Billion
Q1 2023

May 09, 2023
BUY
$680.49 - $826.97 $58,522 - $71,119
86 Added 3.55%
2,506 $2.06 Billion
Q4 2022

Feb 10, 2023
BUY
$705.89 - $766.39 $63,530 - $68,975
90 Added 3.86%
2,420 $1.75 Billion
Q3 2022

Nov 10, 2022
BUY
$573.97 - $724.32 $24,680 - $31,145
43 Added 1.88%
2,330 $1.61 Billion
Q2 2022

Aug 15, 2022
SELL
$548.35 - $738.84 $23,579 - $31,770
-43 Reduced 1.85%
2,287 $1.35 Billion
Q1 2022

May 13, 2022
SELL
$595.12 - $698.43 $25,590 - $30,032
-43 Reduced 1.81%
2,330 $1.63 Billion
Q4 2021

Feb 11, 2022
BUY
$543.48 - $670.97 $144,565 - $178,478
266 Added 12.62%
2,373 $1.5 Billion
Q3 2021

Nov 16, 2021
BUY
$574.03 - $680.96 $235,926 - $279,874
411 Added 24.23%
2,107 $1.28 Billion
Q2 2021

Aug 16, 2021
SELL
$472.8 - $558.54 $201,885 - $238,496
-427 Closed
0 $0
Q1 2021

May 17, 2021
BUY
$446.73 - $548.2 $20,996 - $25,765
47 Added 12.37%
427 $202 Million
Q4 2020

Feb 19, 2021
BUY
$478.3 - $607.98 $181,754 - $231,032
380 New
380 $184 Million

Others Institutions Holding REGN

# of Institutions
1,534
Shares Held
83.6M
Call Options Held
1.22M
Put Options Held
1.51M
View Full List

About REGENERON PHARMACEUTICALS, INC.

REGN Quotes by TradingView
  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $75.3B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Laffer Tengler Investments Portfolio

Follow Laffer Tengler Investments and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Laffer Tengler Investments, based on Form 13F filings with the SEC.

News

Stay updated on Laffer Tengler Investments with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email